Navigation Links
AMD Global Telemedicine Inc. to Unveil New Solutions at ATA 2009 Conference in Las Vegas
Date:4/24/2009

AMD Global Telemedicine Inc. announces the completion of its transformation from a telemedicine device company to that of a Telemedicine Encounter Management Systems company (TEMS™)

North Chelmsford, MA (PRWEB) April 24, 2009 -- AMD Global Telemedicine, Inc., announces the completion of its transformation to a Telemedicine Encounter Management Systems company. AMD will showcase its new end to end clinical telemedicine solutions and capabilities at the American Telemedicine Association (ATA) 2009 Conference in Las Vegas, Nevada April 26-28th.

AMD as a Telemedicine Encounter Management company (TEMS™), becomes the worldwide leading supplier of:

  • Telemedicine Devices
  • Patient Encounter Management Software and techniques
  • Systems Connectivity options
  • Remote patient clinic hardware configurations to fit any environment
  • Telemedicine Program Design and Implementation services

"For many years AMD has provided the market's preeminent diagnostic medical devices delivering the highest standard of quality, versatility, durability and ease of use," said Steve Normandin, President of AMD. "AMD's products have field proven reliability in accommodating any medical specialty from neurology to podiatry, and we are excited as we move into this next phase of telemedicine."

Leveraging its experience in the telemedicine device market, AMD now delivers Encounter Management Systems; the process, techniques and management of the patient/doctor experience before, during and after the consult. New for the ATA show is ADEN™. When used as an integrated Clinic station, ADEN™ controls and captures robust device data and integrates it into the client's EMR system. The ADEN™ offering complements AMD's existing line of Encounter Management software solutions.

AMD also announces enhancements to its connectivity capabilities with systems from the leading videoconference providers as well as a communications option for ADEN™. AMD Dynamic Encounter Network (ADEN™) Connect is the first on-demand, permissions based, live device telemedicine network. It can be used on any TCP/IP network at virtually any speed. ADEN™ allows doctors anywhere in the world to connect to medical devices at any ADEN™ equipped clinic using only an Internet browser. ADEN™ can be deployed with any hard or soft end point video conferencing solution.

For more information on AMD Global Telemedicine, please visit Booth 501 at the ATA Show Las Vegas, Nevada April 26 - 28th.

About AMD Global Telemedicine Inc.
AMD Global Telemedicine Inc. is the leading, worldwide supplier of Telemedicine Encounter Management Systems used in clinical telemedicine at more than 5,200 sites in 74 countries. AMD also provides complete program design, implementation, training and technical support.

Corporate Contacts:
Web Site: www.amdtelemedicine.com
E-mail: pr(at)amdtelemedicine.com
Phone: 1-866-511-0923

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2359454.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care
2. Global health experts release new guidance on malaria elimination
3. Slimband™ Team Competes in CN Tower Climb and Helps Fight Against Global Warming
4. HBA Global Expo and Spa & Resort/Medical Aesthetics Expo to Offer Full Spectrum of the Product Development Cycle
5. Global Med Technologies(R) Licenses ElDorado(TM) Software Solutions to $3.5 Billion MedStar Health of Baltimore, MD
6. Global Health Leaders Gather to Address Urgent Crisis of Prematurity and Stillbirth
7. U.S. Measles Outbreaks Highlight Global Need
8. HBA Global Expo Platforms Private Label/Contract Manufacturing
9. Frost & Sullivan and International Safety Equipment Association (ISEA) Present a Webinar on the Economy: Personal Protective Equipment Industry - Immune to Global Slowdown?
10. Dr. Larry Brilliant Joins Jeff Skoll to Combat Global Challenges
11. As Global Recession Worsens, is Malaria Killing Africas Potential?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the ... a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, ... retirement havens have extremely low property-tax rates, which contributes to the relatively lower ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: